Targeting acid sphingomyelinase with anti-angiogenic chemotherapy

Despite great promise, combining anti-angiogenic and conventional anti-cancer drugs has produced limited therapeutic benefit in clinical trials, presumably because mechanisms of anti-angiogenic tissue response remain only partially understood. Here we define a new paradigm, in which anti-angiogenic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Signal
Main Authors: Jacobi, Jeanna, García-Barros, Mónica, Rao, Shyam, Rotolo, Jimmy A, Thompson, Chris, Mizrachi, Aviram, Feldman, Regina, Manova, Katia, Bielawska, Alicja, Bielawska, Jacek, Fuks, Zvi, Kolesnick, Richard, Haimovitz-Friedman, Adriana
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5138150/
https://ncbi.nlm.nih.gov/pubmed/27702691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellsig.2016.09.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados